The price of Aleve and its generic naproxen equivalent in 2026 will depend on several factors, including patent expirations, market competition, and manufacturer pricing strategies. Currently, both brand-name Aleve and generic naproxen are available.
When Does Aleve's Patent Protection End?
Bayer's Aleve (naproxen sodium) has been available over-the-counter for many years, and its primary patent protection expired long ago, leading to the widespread availability of generic versions [1]. The initial patents for naproxen itself have long since expired, allowing for generic production.
How Much Will Generic Naproxen Cost in 2026?
Generic medications, including naproxen, generally cost significantly less than their brand-name counterparts due to market competition. As of early 2024, a 24-count bottle of 220mg Aleve can range from $10 to $15, while generic naproxen 220mg for a similar quantity can be found for $5 to $10 or less [2][3]. By 2026, the price of generic naproxen is expected to remain competitive, likely staying in a similar or potentially lower range, depending on the number of manufacturers and their production costs.
What is the Price Difference Between Aleve and Generic Naproxen Now?
Currently, generic naproxen is substantially cheaper than brand-name Aleve. This price difference is a common characteristic of the pharmaceutical market once a drug goes off-patent and generic alternatives become available.
Are There Any Alternatives to Aleve and Generic Naproxen?
Other over-the-counter nonsteroidal anti-inflammatory drugs (NSAIDs) available include ibuprofen (Advil, Motrin) and aspirin. Acetaminophen (Tylenol) is a different class of pain reliever (analgesic and antipyretic) that does not have anti-inflammatory properties [4].
What Factors Influence Drug Pricing?
Drug pricing is influenced by research and development costs, manufacturing expenses, marketing, regulatory approval processes, patent exclusivity, and market competition. For generic drugs, the primary driver of price is the level of competition among manufacturers.
Sources:
1. DrugPatentWatch.com
2. GoodRx
3. CVS Pharmacy
4. National Institutes of Health